Forsta AP Fonden Purchases 20,600 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Forsta AP Fonden increased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 160,800 shares of the pharmacy operator’s stock after purchasing an additional 20,600 shares during the quarter. Forsta AP Fonden’s holdings in Walgreens Boots Alliance were worth $7,566,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Strategic Blueprint LLC acquired a new position in Walgreens Boots Alliance in the 2nd quarter valued at about $38,000. Newbridge Financial Services Group Inc. acquired a new position in shares of Walgreens Boots Alliance during the 2nd quarter worth approximately $40,000. Centerpoint Advisors LLC grew its position in shares of Walgreens Boots Alliance by 38.7% during the 3rd quarter. Centerpoint Advisors LLC now owns 986 shares of the pharmacy operator’s stock worth $46,000 after purchasing an additional 275 shares in the last quarter. Strategic Asset Management LLC acquired a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth approximately $66,000. Finally, Dark Forest Capital Management LP acquired a new position in shares of Walgreens Boots Alliance during the 2nd quarter worth approximately $83,000. 55.33% of the stock is currently owned by institutional investors.

WBA stock opened at $54.30 on Friday. The company has a fifty day moving average price of $49.67 and a 200-day moving average price of $48.78. The company has a market capitalization of $46.88 billion, a P/E ratio of 7.32, a PEG ratio of 2.38 and a beta of 0.56. Walgreens Boots Alliance, Inc. has a 52-week low of $43.62 and a 52-week high of $57.05. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.44 and a current ratio of 0.83.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, January 6th. The pharmacy operator reported $1.68 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.35 by $0.33. The firm had revenue of $33.90 billion during the quarter, compared to the consensus estimate of $32.87 billion. Walgreens Boots Alliance had a net margin of 4.76% and a return on equity of 20.28%. The company’s revenue for the quarter was down 6.6% on a year-over-year basis. During the same quarter last year, the firm earned $1.22 earnings per share. As a group, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 5.05 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 10th. Stockholders of record on Monday, November 15th were given a dividend of $0.477 per share. This represents a $1.91 annualized dividend and a dividend yield of 3.51%. The ex-dividend date of this dividend was Friday, November 12th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 25.74%.

Several research firms recently issued reports on WBA. Truist Securities increased their price target on shares of Walgreens Boots Alliance from $52.00 to $56.00 and gave the stock a “hold” rating in a research report on Friday, October 15th. Truist increased their price target on shares of Walgreens Boots Alliance from $52.00 to $56.00 and gave the stock a “hold” rating in a research report on Friday, October 15th. Credit Suisse Group reiterated a “hold” rating and set a $48.00 price target on shares of Walgreens Boots Alliance in a research report on Friday, September 24th. UBS Group increased their price target on shares of Walgreens Boots Alliance from $50.00 to $52.00 and gave the stock a “neutral” rating in a research report on Wednesday, December 22nd. Finally, Morgan Stanley downgraded shares of Walgreens Boots Alliance from an “equal weight” rating to an “underweight” rating and dropped their price objective for the company from $56.00 to $49.00 in a research note on Thursday, December 16th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $54.53.

In other news, Director Nancy M. Schlichting sold 2,725 shares of the stock in a transaction on Friday, November 19th. The shares were sold at an average price of $47.16, for a total transaction of $128,511.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 17.40% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA and Retail Pharmacy International. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.

See Also: Dual Listing What You Need to Know

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.